共查询到20条相似文献,搜索用时 0 毫秒
1.
Jelena uklina Chloe H Lee Evan G Williams Tatjana Sajic Ben C Collins María Rodríguez Martínez Varun S Sharma Fabian Wendt Sandra Goetze Gregory R Keele Bernd Wollscheid Ruedi Aebersold Patrick G A Pedrioli 《Molecular systems biology》2021,17(8)
Advancements in mass spectrometry‐based proteomics have enabled experiments encompassing hundreds of samples. While these large sample sets deliver much‐needed statistical power, handling them introduces technical variability known as batch effects. Here, we present a step‐by‐step protocol for the assessment, normalization, and batch correction of proteomic data. We review established methodologies from related fields and describe solutions specific to proteomic challenges, such as ion intensity drift and missing values in quantitative feature matrices. Finally, we compile a set of techniques that enable control of batch effect adjustment quality. We provide an R package, \"proBatch\", containing functions required for each step of the protocol. We demonstrate the utility of this methodology on five proteomic datasets each encompassing hundreds of samples and consisting of multiple experimental designs. In conclusion, we provide guidelines and tools to make the extraction of true biological signal from large proteomic studies more robust and transparent, ultimately facilitating reliable and reproducible research in clinical proteomics and systems biology. 相似文献
2.
Studying the spatial distribution of proteins provides the basis for understanding the biology, molecular repertoire, and architecture of every human cell. The Human Protein Atlas (HPA) has grown into one of the world''s largest biological databases, and in the most recent version, a major update of the structure of the database was performed. The data has now been organized into 10 different comprehensive sections, each summarizing different aspects of the human proteome and the protein‐coding genes. In particular, large datasets with information on the single cell type level have been integrated, refining the tissue and cell type specificity and detailing the expression in cell states with an increased resolution. The multi‐modal data constitute an important resource for both basic and translational science, and hold promise for integration with novel emerging technologies at the protein and RNA level. 相似文献
3.
Mujdat Zeybel Ozlem Altay Muhammad Arif Xiangyu Li Hong Yang Claudia Fredolini Murat Akyildiz Burcin Saglam Mehmet Gokhan Gonenli Dilek Ural Woonghee Kim Jochen M Schwenk Cheng Zhang Saeed Shoaie Jens Nielsen Mathias Uhln Jan Born Adil Mardinoglu 《Molecular systems biology》2021,17(10)
Nonalcoholic fatty liver disease (NAFLD) refers to excess fat accumulation in the liver. In animal experiments and human kinetic study, we found that administration of combined metabolic activators (CMAs) promotes the oxidation of fat, attenuates the resulting oxidative stress, activates mitochondria, and eventually removes excess fat from the liver. Here, we tested the safety and efficacy of CMA in NAFLD patients in a placebo‐controlled 10‐week study. We found that CMA significantly decreased hepatic steatosis and levels of aspartate aminotransferase, alanine aminotransferase, uric acid, and creatinine, whereas found no differences on these variables in the placebo group after adjustment for weight loss. By integrating clinical data with plasma metabolomics and inflammatory proteomics as well as oral and gut metagenomic data, we revealed the underlying molecular mechanisms associated with the reduced hepatic fat and inflammation in NAFLD patients and identified the key players involved in the host–microbiome interactions. In conclusion, we showed that CMA can be used to develop a pharmacological treatment strategy in NAFLD patients. 相似文献
4.
Alok Jaiswal Prson Gautam Elina A Pietil Sanna Timonen Nora Nordstrm Yevhen Akimov Nina Sipari Ziaurrehman Tanoli Thomas Fleischer Kaisa Lehti Krister Wennerberg Tero Aittokallio 《Molecular systems biology》2021,17(3)
Molecular and functional profiling of cancer cell lines is subject to laboratory‐specific experimental practices and data analysis protocols. The current challenge therefore is how to make an integrated use of the omics profiles of cancer cell lines for reliable biological discoveries. Here, we carried out a systematic analysis of nine types of data modalities using meta‐analysis of 53 omics studies across 12 research laboratories for 2,018 cell lines. To account for a relatively low consistency observed for certain data modalities, we developed a robust data integration approach that identifies reproducible signals shared among multiple data modalities and studies. We demonstrated the power of the integrative analyses by identifying a novel driver gene, ECHDC1, with tumor suppressive role validated both in breast cancer cells and patient tumors. The multi‐modal meta‐analysis approach also identified synthetic lethal partners of cancer drivers, including a co‐dependency of PTEN deficient endometrial cancer cells on RNA helicases. 相似文献
5.
Hongzhong Lu Feiran Li Le Yuan Ivn Domenzain Rosemary Yu Hao Wang Gang Li Yu Chen Boyang Ji Eduard J Kerkhoven Jens Nielsen 《Molecular systems biology》2021,17(10)
Yeasts are known to have versatile metabolic traits, while how these metabolic traits have evolved has not been elucidated systematically. We performed integrative evolution analysis to investigate how genomic evolution determines trait generation by reconstructing genome‐scale metabolic models (GEMs) for 332 yeasts. These GEMs could comprehensively characterize trait diversity and predict enzyme functionality, thereby signifying that sequence‐level evolution has shaped reaction networks towards new metabolic functions. Strikingly, using GEMs, we can mechanistically map different evolutionary events, e.g. horizontal gene transfer and gene duplication, onto relevant subpathways to explain metabolic plasticity. This demonstrates that gene family expansion and enzyme promiscuity are prominent mechanisms for metabolic trait gains, while GEM simulations reveal that additional factors, such as gene loss from distant pathways, contribute to trait losses. Furthermore, our analysis could pinpoint to specific genes and pathways that have been under positive selection and relevant for the formulation of complex metabolic traits, i.e. thermotolerance and the Crabtree effect. Our findings illustrate how multidimensional evolution in both metabolic network structure and individual enzymes drives phenotypic variations. 相似文献
6.
YanMei Chen Yuanting Zheng Ying Yu Yunzhi Wang Qingxia Huang Feng Qian Lei Sun ZhiGang Song Ziyin Chen Jinwen Feng Yanpeng An Jingcheng Yang Zhenqiang Su Shanyue Sun Fahui Dai Qinsheng Chen Qinwei Lu Pengcheng Li Yun Ling Zhong Yang Huiru Tang Leming Shi Li Jin Edward C Holmes Chen Ding TongYu Zhu YongZhen Zhang 《The EMBO journal》2020,39(24)
7.
Yongxiang Zhang Jingkai Wang Chao Yu Kaishun Xia Biao Yang Yuang Zhang Liwei Ying Chenggui Wang Xianpeng Huang Qixin Chen Li Shen Fangcai Li Chengzhen Liang 《Cell proliferation》2022,55(1)
In recent years, single‐cell sequencing (SCS) technologies have continued to advance with improved operating procedures and reduced cost, leading to increasing practical adoption among researchers. These emerging technologies have superior abilities to analyse cell heterogeneity at a single‐cell level, which have elevated multi‐omics research to a higher level. In some fields of research, application of SCS has enabled many valuable discoveries, and musculoskeletal system offers typical examples. This article reviews some major scientific issues and recent advances in musculoskeletal system. In addition, combined with SCS technologies, the research of cell or tissue heterogeneity in limb development and various musculoskeletal system clinical diseases also provides new possibilities for treatment strategies. Finally, this article discusses the challenges and future development potential of SCS and recommends the direction of future applications of SCS to musculoskeletal medicine. 相似文献
8.
Growing evidence has shown that Transmembrane Serine Protease 2 (TMPRSS2) not only contributes to the severe acute respiratory syndrome coronavirus 2 (SARS‐CoV‐2) infection, but is also closely associated with the incidence and progression of tumours. However, the correlation of coronavirus disease (COVID‐19) and cancers, and the prognostic value and molecular function of TMPRSS2 in various cancers have not been fully understood. In this study, the expression, genetic variations, correlated genes, immune infiltration and prognostic value of TMPRSS2 were analysed in many cancers using different bioinformatics platforms. The observed findings revealed that the expression of TMPRSS2 was considerably decreased in many tumour tissues. In the prognostic analysis, the expression of TMPRSS2 was considerably linked with the clinical consequences of the brain, blood, colorectal, breast, ovarian, lung and soft tissue cancer. In protein network analysis, we determined 27 proteins as protein partners of TMPRSS2, which can regulate the progression and prognosis of cancer mediated by TMPRSS2. Besides, a high level of TMPRSS2 was linked with immune cell infiltration in various cancers. Furthermore, according to the pathway analysis of differently expressed genes (DEGs) with TMPRSS2 in lung, breast, ovarian and colorectal cancer, 160 DEGs genes were found and were significantly enriched in respiratory system infection and tumour progression pathways. In conclusion, the findings of this study demonstrate that TMPRSS2 may be an effective biomarker and therapeutic target in various cancers in humans, and may also provide new directions for specific tumour patients to prevent SARS‐CoV‐2 infection during the COVID‐19 outbreak. 相似文献
9.
10.
Author‐level metrics are a widely used measure of scientific success. The h‐index and its variants measure publication output (number of publications) and research impact (number of citations). They are often used to influence decisions, such as allocating funding or jobs. Here, we argue that the emphasis on publication output and impact hinders scientific progress in the fields of ecology and evolution because it disincentivizes two fundamental practices: generating impactful (and therefore often long‐term) datasets and sharing data. We describe a new author‐level metric, the data‐index, which values both dataset output (number of datasets) and impact (number of data‐index citations), so promotes generating and sharing data as a result. We discuss how it could be implemented and provide user guidelines. The data‐index is designed to complement other metrics of scientific success, as scientific contributions are diverse and our value system should reflect that both for the benefit of scientific progress and to create a value system that is more equitable, diverse, and inclusive. Future work should focus on promoting other scientific contributions, such as communicating science, informing policy, mentoring other scientists, and providing open‐access code and tools. 相似文献
11.
12.
Aurelien Dugourd Christoph Kuppe Marco Sciacovelli Enio Gjerga Attila Gabor Kristina B. Emdal Vitor Vieira Dorte B. BekkerJensen Jennifer Kranz Eric.M.J. Bindels Ana S.H. Costa Abel Sousa Pedro Beltrao Miguel Rocha Jesper V. Olsen Christian Frezza Rafael Kramann Julio SaezRodriguez 《Molecular systems biology》2021,17(1)
14.
Dimitrios Konstantinidis Filipa Pereira EvaMaria Geissen Kristina Grkovska Eleni Kafkia Paula Jouhten Yongkyu Kim Saravanan Devendran Michael Zimmermann Kiran Raosaheb Patil 《Molecular systems biology》2021,17(8)
Adaptive laboratory evolution has proven highly effective for obtaining microorganisms with enhanced capabilities. Yet, this method is inherently restricted to the traits that are positively linked to cell fitness, such as nutrient utilization. Here, we introduce coevolution of obligatory mutualistic communities for improving secretion of fitness‐costly metabolites through natural selection. In this strategy, metabolic cross‐feeding connects secretion of the target metabolite, despite its cost to the secretor, to the survival and proliferation of the entire community. We thus co‐evolved wild‐type lactic acid bacteria and engineered auxotrophic Saccharomyces cerevisiae in a synthetic growth medium leading to bacterial isolates with enhanced secretion of two B‐group vitamins, viz., riboflavin and folate. The increased production was specific to the targeted vitamin, and evident also in milk, a more complex nutrient environment that naturally contains vitamins. Genomic, proteomic and metabolomic analyses of the evolved lactic acid bacteria, in combination with flux balance analysis, showed altered metabolic regulation towards increased supply of the vitamin precursors. Together, our findings demonstrate how microbial metabolism adapts to mutualistic lifestyle through enhanced metabolite exchange. 相似文献
15.
Urmila Dyola Chitra Bahadur Baniya Pushpa Raj Acharya Pradip Subedi Anjeela Pandey Kumar Sapkota 《Ecology and evolution》2022,12(3)
Insect pollinators are important means for a stable ecosystem. The habitat types play a crucial role in the community composition, abundance, diversity, and species richness of the pollinators. The present study in Shivapuri‐Nagarjun National Park explored the species richness and abundances of insect pollinators in four different habitats and different environmental variables in determining the community composition of the pollinators. Data were collected from 1,500 m to 2,700 m using color pan traps and hand sweeping methods. Non‐Metric Multidimensional Scaling (NMDS) and Redundancy Analysis (RDA) were conducted to show the association between insect pollinators and environmental variables. The results firmly demonstrated that species richness and abundances were higher (158) in Open trail compared to other habitats. The distribution of the pollinator species was more uniform in the Open trail followed by the Grassland. Similarly, a strong positive correlation between flower resources and pollinators'' abundance (R2 = .63, P < .001) was found. In conclusion, the Open trail harbors rich insect pollinators in lower elevation. The community structure of the pollinators was strongly influenced by the presence of flowers in the trails. 相似文献
16.
YenDun Tony Tzeng KuanHao Tsui LingMing Tseng MingFeng Hou PeiYi Chu Jim JinnChyuan Sheu ChiaJung Li 《Journal of cellular and molecular medicine》2022,26(14):4007
The discovery of early diagnosis and prognostic markers for breast cancer can significantly improve survival and reduce mortality. LSM1 is known to be involved in the general process of mRNA degradation in complexes containing LSm subunits, but the molecular and biological functions in breast cancer remain unclear. Here, the expression of LSM1 mRNA in breast cancer was estimated using The Cancer Genome Atlas (TCGA), Oncomine, TIMER and bc‐GenExMiner databases. We found that functional LSM1 inactivation caused by mutations and profound deletions predicted poor prognosis in breast cancer (BRCA) patients. LSM1 was highly expressed in both BRCA tissues and cells compared to normal breast tissues/cells. High LSM1 expression is associated with poorer overall survival and disease‐free survival. The association between LSM1 and immune infiltration of breast cancer was assessed by TIMER and CIBERSORT algorithms. LSM1 showed a strong correlation with various immune marker sets. Most importantly, pharmacogenetic analysis of BRCA cell lines revealed that LSM1 inactivation was associated with increased sensitivity to refametinib and trametinib. However, both drugs could mimic the effects of LSM1 inhibition and their drug sensitivity was associated with MEK molecules. Therefore, we investigated the clinical application of LSM1 to provide a basis for sensitive diagnosis, prognosis and targeted treatment of breast cancer. 相似文献
17.
18.
19.
PeterMartin Bruch Holly AR Giles Carolin Kolb Sophie A Herbst Tina Becirovic Tobias Roider Junyan Lu Sebastian Scheinost Lena Wagner Jennifer Huellein Ivan Berest Mark Kriegsmann Katharina Kriegsmann Christiane Zgorzelski Peter Dreger Judith B Zaugg Carsten MüllerTidow Thorsten Zenz Wolfgang Huber Sascha Dietrich 《Molecular systems biology》2022,18(8)
The tumour microenvironment and genetic alterations collectively influence drug efficacy in cancer, but current evidence is limited and systematic analyses are lacking. Using chronic lymphocytic leukaemia (CLL) as a model disease, we investigated the influence of 17 microenvironmental stimuli on 12 drugs in 192 genetically characterised patient samples. Based on microenvironmental response, we identified four subgroups with distinct clinical outcomes beyond known prognostic markers. Response to multiple microenvironmental stimuli was amplified in trisomy 12 samples. Trisomy 12 was associated with a distinct epigenetic signature. Bromodomain inhibition reversed this epigenetic profile and could be used to target microenvironmental signalling in trisomy 12 CLL. We quantified the impact of microenvironmental stimuli on drug response and their dependence on genetic alterations, identifying interleukin 4 (IL4) and Toll‐like receptor (TLR) stimulation as the strongest actuators of drug resistance. IL4 and TLR signalling activity was increased in CLL‐infiltrated lymph nodes compared with healthy samples. High IL4 activity correlated with faster disease progression. The publicly available dataset can facilitate the investigation of cell‐extrinsic mechanisms of drug resistance and disease progression. 相似文献
20.
Kuoyuan Cheng Laura MartinSancho Lipika R Pal Yuan Pu Laura Riva Xin Yin Sanju Sinha Nishanth Ulhas Nair Sumit K Chanda Eytan Ruppin 《Molecular systems biology》2021,17(11)
Tremendous progress has been made to control the COVID‐19 pandemic caused by the SARS‐CoV‐2 virus. However, effective therapeutic options are still rare. Drug repurposing and combination represent practical strategies to address this urgent unmet medical need. Viruses, including coronaviruses, are known to hijack host metabolism to facilitate viral proliferation, making targeting host metabolism a promising antiviral approach. Here, we describe an integrated analysis of 12 published in vitro and human patient gene expression datasets on SARS‐CoV‐2 infection using genome‐scale metabolic modeling (GEM), revealing complicated host metabolism reprogramming during SARS‐CoV‐2 infection. We next applied the GEM‐based metabolic transformation algorithm to predict anti‐SARS‐CoV‐2 targets that counteract the virus‐induced metabolic changes. We successfully validated these targets using published drug and genetic screen data and by performing an siRNA assay in Caco‐2 cells. Further generating and analyzing RNA‐sequencing data of remdesivir‐treated Vero E6 cell samples, we predicted metabolic targets acting in combination with remdesivir, an approved anti‐SARS‐CoV‐2 drug. Our study provides clinical data‐supported candidate anti‐SARS‐CoV‐2 targets for future evaluation, demonstrating host metabolism targeting as a promising antiviral strategy. 相似文献